AbbVie to Invest $380 Million to Expand Active Pharmaceutical Ingredient Manufacturing in North Chicago

AbbVie announced a $380 million investment to expand its North Chicago facility, boosting active pharmaceutical ingredient manufacturing in the U.S. This move aims to enhance supply chain resilience and support drug innovation.

—-

Author : William Green

Publish date : 2026-02-23 23:02:00

Copyright for syndicated content belongs to the linked Source.

—-

1 – 2 – 3 – 4 – 5 – 6 – 7 – 8